American Heart Journal
Volume 154, Issue 5 , Pages 884-892 , November 2007

Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias

  • Sanjeev Saksena, MD, FHRS, FESC, FACC

      Affiliations

    • Electrophysiology Research Foundation and Robert Wood Johnson Medical School, Warren and New Brunswick, NJ
    • Corresponding Author InformationReprint requests: Sanjeev Saksena, MD, FHRS, FESC, FACC, Electrophysiology Research Foundation, 161 Washington Valley Road, Suite 201, Warren, NJ 07059.
    • Drs. Saksena and Padeletti are consultants and investigators for several pacemaker and drug companies.
    • ,
  • Douglas A. Hettrick, PhD

      Affiliations

    • Medtronic, Inc, Minneapolis, MN
    • Dr. Hettrick, Mr. Grammatico and Ms. Koehler are employees of Medtronic Inc.
    • ,
  • Jodi L. Koehler, MS

      Affiliations

    • Medtronic, Inc, Minneapolis, MN
    • Dr. Hettrick, Mr. Grammatico and Ms. Koehler are employees of Medtronic Inc.
    • ,
  • Andrea Grammatico, BS

      Affiliations

    • Medtronic, Inc, Minneapolis, MN
    • Dr. Hettrick, Mr. Grammatico and Ms. Koehler are employees of Medtronic Inc.
    • ,
  • Luigi Padeletti, MD

      Affiliations

    • University of Florence, Florence, Italy
    • Drs. Saksena and Padeletti are consultants and investigators for several pacemaker and drug companies.

Received 9 April 2007 ,Accepted 11 June 2007.

References 

  1. Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954–1968
  2. Padeletti L, Santini M, Boriani G, et al. Long-term reduction of atrial tachyarrhythmia recurrences in patients paced for bradycardia-tachycardia syndrome. Heart Rhythm. 2005;2:1047–1057
  3. Gillis AM, Morck M. Atrial fibrillation after DDDR pacemaker implantation. J Cardiovasc Electrophysiol. 2002;13:542–547
  4. Padeletti L, Purerfellner H, Adler SW, et al. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol. 2003;14:1189–1195
  5. Strickberger SA, Adam S, Ip J, et al. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm. 2005;2:125–131
  6. Gregoratos G, Abrams J, Epstein AE, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation. 2002;106:2145–2161
  7. Purerfellner H, Gillis AM, Holbrook R, et al. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol. 2004;27:983–992
  8. Inama G, Santini M, Padeletti L, et al. Far-field R wave oversensing in dual chamber pacemakers designed for atrial arrhythmia management: effect of pacing site and lead tip to ring distance. Pacing Clin Electrophysiol. 2004;27:1221–1230
  9. Willems R, Wyse DG, Gillis AM, et al. Total atrioventricular nodal ablation increases atrial fibrillation burden in patients with paroxysmal atrial fibrillation despite continuation of antiarrhythmic drug therapy. J Cardiovasc Electrophysiol. 2003;14:1296–1301
  10. Levy S, Camm AJ, Saksena S, et al. International consensus on nomenclature and classification of atrial fibrillation: a collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol. 2003;14:443–445
  11. Saksena S, Skadsberg N, Rao H, et al. Biatrial and three dimensional mapping of spontaneous atrial arrhythmias in patients with refractory atrial fibrillation. J Cardiovasc Electrophysiol. 2005;16:505–507
  12. Hettrick DA, Adler S, Padeletti L, et al. Progression of atrial tachyarrhythmia burden over time in patients with vs. without structural cardiovascular disease. Heart Rhythm. 2004;1:S272;[abstract]
  13. Gillis AM, Connolly SJ, Lacombe P, et al. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators. Circulation. 2000;102:736–741
  14. Israel CW, Gronefeld G, Ehrlich JR, et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol. 2004;43:47–52
  15. Madrid AH, Peng J, Zamora J, et al. The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta analyses of randomized controlled trials. PACE. 2004;27:1405–1410
  16. Ueng KC, Tsai TP, Yu WC, et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J. 2003;24:2090–2098
  17. Alsheikh-Ali AA, Wang PJ, Rand W, et al. Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction. Am Heart J. 2004;147:1061–1065
  18. Prakash A, Saksena S, Ziegler PD, et al. for the DAPPAF Investigators Dual site right atrial pacing can improve the impact of standard dual chamber pacing on atrial and ventricular mechanical function in patients with symptomatic atrial fibrillation: further observations from the dual site atrial pacing for prevention of atrial fibrillation trial. J Intervent Card Electrophysiol. 2005;12:177–187
  19. Capucci A, Santini M, Padeletti L, et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol. 2005;46:1913–1920
  20. Madan N, Ibrahim E, Saksena S. Withdrawal or maintenance of warfarin therapy guided by implantable device datalogs in patients with refractory atrial fibrillation: a novel application of device monitoring in recurrent atrial fibrillation. J Am Coll Cardiol. 2005;45:1079–1249

PII: S0002-8703(07)00599-6

doi: 10.1016/j.ahj.2007.06.045

American Heart Journal
Volume 154, Issue 5 , Pages 884-892 , November 2007

Article Tools

* Image Usage & Resolution